Proteome Sciences (LON:PRM) Hits New 12-Month Low – Should You Sell?

Proteome Sciences plc (LON:PRMGet Free Report) shares hit a new 52-week low during trading on Wednesday . The company traded as low as GBX 2.30 ($0.03) and last traded at GBX 2.78 ($0.04), with a volume of 455149 shares. The stock had previously closed at GBX 2.60 ($0.03).

Proteome Sciences Stock Performance

The firm has a 50 day moving average price of GBX 2.84 and a two-hundred day moving average price of GBX 3.32. The company has a market capitalization of £8.19 million, a P/E ratio of -277.50 and a beta of 0.07.

About Proteome Sciences

(Get Free Report)

Proteome Sciences plc provides contract research services for the identification, validation, and application of protein biomarkers in the United States, the United Kingdom, European Union, and internationally. The company offers TMT LC-MS2, a standard method for analyzing cells and tissues when no phosphopeptide enrichment is required; TMT LC-MS3, a standard method for biomarker discovery in plasma and other samples where quantitative accuracy is a factor; SysQuant, provides an analysis of protein activity across regulatory and signaling pathways; and TMTcalibrator, analyzes where diseased or treated tissue can be analyzed in parallel with peripheral fluids.

Featured Stories

Receive News & Ratings for Proteome Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Proteome Sciences and related companies with MarketBeat.com's FREE daily email newsletter.